Intravenous Fibrinolysis Eligibility: A Survey of Stroke Clinicians' Practice Patterns and Review of the Literature-Reference-Cited by-同舟云学术

Intravenous Fibrinolysis Eligibility: A Survey of Stroke Clinicians' Practice Patterns and Review of the Literature

Published:2014-09 Issue:8 Volume:23 Page:2130-2138
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

De Los Rios Felipe,Kleindorfer Dawn O.,Guzik Amy,Ortega-Gutierrez Santiago,Sangha Navdeep,Kumar Gyanendra,Grotta James C.,Lee Jin-Moo,Meyer Brett C.,Schwamm Lee H.,Khatri Pooja

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Neurology (clinical),Rehabilitation,Surgery

Reference37 articles.

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group;The New England journal of medicine,1995

2. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke;Hacke;NEnglJMed,2008

3. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial;Sandercock;Lancet,2012

4. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis;Wardlaw;Lancet,2012

5. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years;Adeoye;Stroke,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with End-Stage Renal Disease on Hemodialysis: A Narrative Review;Journal of Cardiovascular Development and Disease;2022-12-09

2. Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction;Stroke;2019-10

3. Safety and Efficacy of Repeated Thrombolysis with Alteplase in Early Recurrent Ischemic Stroke: A Systematic Review;Journal of Stroke and Cerebrovascular Diseases;2019-10

4. Emergency Management of Epilepsy and Seizures;Seminars in Neurology;2019-02

5. Does the Addition of Non-Approved Inclusion and Exclusion Criteria for rtPA Impact Treatment Rates? Findings in Australia, the UK, and the USA;Interventional Neurology;2018-09-25